A shadow economy for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.
Investigational Drug Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to message these accounts privately for supplier links, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Separately, a flourishing trade exists on Telegram, where communities with thousands of participants share comparison photos, administration instructions and assertions of next-day UK delivery. Vendors market the substance there before redirecting customers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in users injecting products of unknown origin.
Several professionals stated the popularity for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.
Some content creators try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate medicines, marketing, and customer regulations, potentially leading to penalties, prosecution or imprisonment.
Service Response and Content Removal
Based on TikTok, the service has taken down problematic content and prohibited related keywords and query recommendations. The company said it was committed to maintaining the platform safe and investing in enhancing enforcement strategies.
Online Trading Activities
Research also found groups with up to 9,000 members marketing the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, populated with photos of weight loss, glowing reviews and detailed guides for mixing or injecting at residence.
Within minutes of joining one community, a seller shared contact information, where the majority of transactions occur. The seller sent an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about body mass, medical conditions or past usage.
Item Information and Pricing
Within these communities, messages display dark colored parcels with Royal Mail labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at home with purified liquid, or ready-to-use pens typically priced at £160 for 20mg. When asked how long a pen should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for the messaging service said it actively moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering substances they can’t verify. Although the research behind retatrutide is sound, these digital versions may not contain what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of an online medical service linked the increase in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With costs rising, patients are turning to social media. But fake injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.
Her team has previously seen individuals harmed by personal administration from unverified suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”
Producer Position
A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company experimental product not yet authorized … may subject patients to potentially significant medical dangers”.
